DK0501821T3 - Antitrombinpolypeptider - Google Patents

Antitrombinpolypeptider

Info

Publication number
DK0501821T3
DK0501821T3 DK92301721T DK92301721T DK0501821T3 DK 0501821 T3 DK0501821 T3 DK 0501821T3 DK 92301721 T DK92301721 T DK 92301721T DK 92301721 T DK92301721 T DK 92301721T DK 0501821 T3 DK0501821 T3 DK 0501821T3
Authority
DK
Denmark
Prior art keywords
polypeptides
thrombin
preparation
hirudinaria manillensis
recombinant
Prior art date
Application number
DK92301721T
Other languages
Danish (da)
English (en)
Inventor
Paolo Sarmientos
Taxis Du Poet Philippe De
Giampaolo Nitti
Emanuela Scacheri
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919104260A external-priority patent/GB9104260D0/en
Priority claimed from GB919119954A external-priority patent/GB9119954D0/en
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Application granted granted Critical
Publication of DK0501821T3 publication Critical patent/DK0501821T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20211Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92301721T 1991-02-28 1992-02-28 Antitrombinpolypeptider DK0501821T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919104260A GB9104260D0 (en) 1991-02-28 1991-02-28 Anti-thrombin polypeptides
GB919119954A GB9119954D0 (en) 1991-09-18 1991-09-18 Antithrombin polypeptides

Publications (1)

Publication Number Publication Date
DK0501821T3 true DK0501821T3 (da) 1999-08-30

Family

ID=26298509

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92301721T DK0501821T3 (da) 1991-02-28 1992-02-28 Antitrombinpolypeptider

Country Status (23)

Country Link
US (2) US5356875A (xx)
EP (1) EP0501821B1 (xx)
JP (1) JPH05247090A (xx)
KR (1) KR100218818B1 (xx)
CN (1) CN1044479C (xx)
AT (1) ATE175236T1 (xx)
AU (1) AU643876B2 (xx)
CA (1) CA2061920A1 (xx)
CZ (1) CZ283458B6 (xx)
DE (1) DE69228015T2 (xx)
DK (1) DK0501821T3 (xx)
ES (1) ES2129426T3 (xx)
FI (1) FI920861A (xx)
GR (1) GR3029364T3 (xx)
HU (1) HU215580B (xx)
IE (1) IE920622A1 (xx)
IL (1) IL101062A0 (xx)
MX (1) MX9200795A (xx)
MY (1) MY110327A (xx)
NO (1) NO300138B1 (xx)
NZ (1) NZ241715A (xx)
TW (1) TW214556B (xx)
YU (1) YU19792A (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1266561B1 (it) * 1993-07-22 1997-01-09 Mini Ricerca Scient Tecnolog Analoghi di un polipeptide anti-trombinico e procedimento per la loro preparazione
CN1064968C (zh) * 1996-07-10 2001-04-25 中国人民解放军第一军医大学 重组蛋白提取纯化方法
NZ336793A (en) * 1997-01-20 2000-08-25 Japan Energy Corp Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
US6077825A (en) 1997-03-13 2000-06-20 Auburn University Antithrombin protein and DNA sequences from black fly
JP2000080046A (ja) * 1998-09-03 2000-03-21 Dai Ichi Seiyaku Co Ltd 多臓器障害の予防・治療剤
CN102876654A (zh) * 2012-10-19 2013-01-16 广东海洋大学 一种桑蚕丝素固定化凝血酶的制备方法
CN104193809B (zh) * 2014-09-28 2016-08-17 顾玉奎 一种凝血酶抑制及其制备方法、应用
CN104193807B (zh) * 2014-09-28 2016-06-15 广州贝奥吉因生物科技有限公司 凝血酶抑制多肽及其制备方法、应用
CN105646702B (zh) * 2016-04-13 2019-03-01 中国科学院昆明动物研究所 菲牛蛭Kazal型胰蛋白酶抑制剂Bdellin-HM及其编码基因和应用
CN108059672B (zh) * 2016-11-08 2021-06-11 中国科学院昆明动物研究所 森林山蛭抗血栓肽Sylvestin及其基因和应用
CN110468174A (zh) * 2019-08-21 2019-11-19 北京中医药大学 一种水蛭活性寡肽的制备方法
CN111454352B (zh) * 2020-03-05 2021-07-23 中国科学院昆明动物研究所 一种活性蛋白hmei-a、活性蛋白hmei-a的编码基因及应用
CN112114069B (zh) * 2020-09-18 2023-05-16 江苏艾迪药业股份有限公司 凝血酶的亲和色谱柱、制备方法及应用
CN112480210B (zh) * 2020-11-25 2021-09-17 广东海洋大学 一种抗凝血活性肽及其用途
KR102354461B1 (ko) * 2021-02-19 2022-01-20 김건언 덕트 일체형 조명등기구
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
GB8826428D0 (en) * 1988-11-11 1988-12-14 Biopharm Ltd Antithrombin
IT1250689B (it) * 1991-07-22 1995-04-21 Marco Gerna Analoghi dell'irudina e procedimento per la loro preparazione

Also Published As

Publication number Publication date
AU643876B2 (en) 1993-11-25
NO920777D0 (no) 1992-02-27
DE69228015D1 (de) 1999-02-11
FI920861A0 (fi) 1992-02-26
HUT64592A (en) 1994-01-28
MX9200795A (es) 1992-08-01
US5356875A (en) 1994-10-18
KR920016468A (ko) 1992-09-24
KR100218818B1 (ko) 1999-10-01
ES2129426T3 (es) 1999-06-16
NZ241715A (en) 1993-07-27
NO300138B1 (no) 1997-04-14
EP0501821B1 (en) 1998-12-30
HU9200620D0 (en) 1992-05-28
CN1066272A (zh) 1992-11-18
YU19792A (sh) 1994-06-10
CA2061920A1 (en) 1992-08-29
FI920861A (fi) 1992-08-29
CZ283458B6 (cs) 1998-04-15
HU215580B (hu) 1999-01-28
CS58492A3 (en) 1992-09-16
IE920622A1 (en) 1992-09-09
AU1122192A (en) 1992-09-03
EP0501821A2 (en) 1992-09-02
IL101062A0 (en) 1992-11-15
NO920777L (no) 1992-08-31
DE69228015T2 (de) 1999-06-02
EP0501821A3 (en) 1993-03-03
GR3029364T3 (en) 1999-05-28
MY110327A (en) 1998-04-30
TW214556B (xx) 1993-10-11
CN1044479C (zh) 1999-08-04
US5439820A (en) 1995-08-08
ATE175236T1 (de) 1999-01-15
JPH05247090A (ja) 1993-09-24

Similar Documents

Publication Publication Date Title
DE69228015D1 (de) Antithrombin-Polypeptide
EP1484339A3 (en) Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
BR0109494A (pt) Produção de fatores recombinantes de coagulação do sangue em linhas celulares humanas
DE3588254D1 (de) Gag-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
DE69433742D1 (de) Bmp-10 zusammensetzungen
HUT68021A (en) Improved activating process of recombinant proteins
WO2001005810A3 (de) CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6?
KR950702579A (ko) 트롬빈 억제제(thrombin inhibitors)
NO892266D0 (no) Amblyommin, et nytt virkemiddel for antikoagulasjonsterapien.
JP2004521076A5 (xx)
DK0769056T3 (da) Ikke-splejsende verianter af gp350/220
ATE338770T1 (de) Mit bh4 fusionierte polypeptide
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
Sarmientos et al. Anti-thrombin polypeptides
FR2387240A1 (fr) Procede de preparation d'albumine humaine
KR19980020377A (ko) 거머린(Guamerin)에서 유도된 단백질분해효소 억제활성을 지닌 펩타이드
Tani et al. Academy of Dental Materials
DE4011375A1 (de) Hirudinpolyvinyllactamkonjugate